Biotech Values

[jbog]

Dew

1Q24 Daxxify sales were $22.1M, -8% QoQ — due to $2.0M of redeemed coupons and normal seasonality in the aesthetics business — and +44% YoY.

I'm sure there has to be some amount of sales attributed to therapeutics. Would you have any guess?

• 1Q24 dermal-filler sales were 29.6M, -14% QoQ and -2% YoY.

Not being familiar with the landscape of fillers, has someone come out with a superior product" If not there must be something wrong with the injectors relationship.